TMO:NYE-Thermo Fisher Scientific Inc (USD)

EQUITY | Diagnostics & Research | New York Stock Exchange

Last Closing

USD 572.38

Change

+1.13 (+0.20)%

Market Cap

USD 56.05B

Volume

1.75M

Analyst Target

USD 451.22
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Thermo Fisher Scientific Inc offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-5.79 (-2.17%)

USD 197.84B
A Agilent Technologies Inc

-2.32 (-1.52%)

USD 44.80B
IQV IQVIA Holdings Inc

+1.06 (+0.47%)

USD 42.82B
MTD Mettler-Toledo International I..

-22.48 (-1.50%)

USD 32.52B
WAT Waters Corporation

-12.01 (-3.44%)

USD 21.11B
LH Laboratory Corporation of Amer..

-4.10 (-2.04%)

USD 17.75B
DGX Quest Diagnostics Incorporated

-1.82 (-1.28%)

USD 15.38B
RVTY Revvity Inc.

-0.78 (-0.69%)

USD 13.27B
CRL Charles River Laboratories

-1.45 (-0.66%)

USD 11.49B
QGEN Qiagen NV

-0.33 (-0.76%)

USD 10.07B

ETFs Containing TMO

XDNA 9.55 % 0.00 %

N/A

N/A
SYNB Putnam Biorevolution ETF 7.30 % 0.00 %

-0.14 (-0.22%)

USD 5.43M
LIFE-B:CA Evolve Global Healthcare .. 4.99 % 0.00 %

+0.02 (+-0.22%)

CAD 0.01B
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.85 % 0.00 %

-0.07 (-0.22%)

USD 3.60M
XGES:LSE Xtrackers MSCI Genomic He.. 4.78 % 0.00 %

-0.07 (-0.22%)

USD 3.60M
AILG 4.51 % 0.00 %

N/A

N/A
IHCU:LSE iShares S&P 500 Health Ca.. 4.28 % 0.00 %

-3.00 (-0.22%)

USD 1.69B
IUHC:LSE iShares S&P 500 USD Healt.. 4.25 % 0.00 %

-0.04 (-0.22%)

USD 2.29B
IUHC:SW iShares S&P 500 Health Ca.. 4.23 % 0.00 %

N/A

USD 0.15M
ZPDH:F SPDR S&P U.S. Health Care.. 4.22 % 0.00 %

-0.31 (-0.22%)

USD 0.40B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 4.22 % 0.00 %

-0.11 (-0.22%)

USD 0.40B
GXLV:LSE SPDR® S&P® U.S. Health .. 4.22 % 0.00 %

-0.11 (-0.22%)

USD 0.40B
SXLV:SW SPDR S&P U.S. Health Care.. 4.22 % 0.00 %

N/A

N/A
QDVG:F iShares S&P 500 Health Ca.. 4.21 % 0.00 %

-0.07 (-0.22%)

USD 2.09B
QDVG:XETRA iShares S&P 500 Health Ca.. 4.21 % 0.00 %

-0.03 (-0.22%)

USD 2.05B
XSHC:LSE Xtrackers MSCI USA Health.. 4.13 % 0.00 %

-15.25 (-0.22%)

USD 0.82B
XUHC:LSE Xtrackers MSCI USA Health.. 4.13 % 0.00 %

-0.27 (-0.22%)

USD 0.82B
XUHC:F Xtrackers (IE) Public Lim.. 4.10 % 0.00 %

-0.35 (-0.22%)

USD 0.85B
XUHC:XETRA Xtrackers MSCI USA Health.. 4.10 % 0.00 %

-0.15 (-0.22%)

USD 0.85B
XUHC:SW Xtrackers MSCI USA Health.. 4.10 % 0.00 %

-0.12 (-0.22%)

USD 0.82B
MHCD:CA Middlefield Healthcare Di.. 4.09 % 0.00 %

-0.11 (-0.22%)

CAD 0.16B
WH2E:XETRA Invesco Markets II plc - .. 3.83 % 0.00 %

+0.01 (+-0.22%)

USD 2.42M
DRUG:AU BetaShares Global Healthc.. 3.58 % 0.00 %

+0.01 (+-0.22%)

USD 0.17B
PINK Simplify Exchange Traded .. 3.53 % 0.00 %

-0.28 (-0.22%)

USD 0.12B
CDNA:CA CI Bio-Revolution ETF 3.34 % 0.00 %

N/A

CAD 5.70M
WELG:XETRA Amundi S&P Global Health .. 3.18 % 0.00 %

N/A

USD 0.25B
WELS:XETRA Amundi S&P Global Health .. 3.18 % 0.00 %

N/A

USD 0.25B
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 3.16 % 0.00 %

+4.75 (+-0.22%)

USD 0.35B
XVTD:LSE Xtrackers - FTSE Vietnam .. 3.16 % 0.00 %

+0.28 (+-0.22%)

USD 0.33B
CURE Direxion Daily Healthcare.. 3.14 % 1.06 %

-3.92 (-0.22%)

USD 0.20B
IXJ iShares Global Healthcare.. 3.04 % 0.46 %

-0.80 (-0.22%)

USD 4.04B
XDWH:LSE Xtrackers MSCI World Heal.. 2.93 % 0.00 %

-0.20 (-0.22%)

USD 2.61B
XDWH:F Xtrackers (IE) Public Lim.. 2.93 % 0.00 %

-0.25 (-0.22%)

USD 2.60B
XDWH:XETRA Xtrackers MSCI World Heal.. 2.93 % 0.00 %

-0.04 (-0.22%)

USD 2.60B
XWHS:LSE Xtrackers MSCI World Heal.. 2.93 % 0.00 %

-0.10 (-0.22%)

USD 2.62B
WHEA:LSE SPDR® MSCI World Health .. 2.93 % 0.00 %

-0.17 (-0.22%)

USD 0.58B
HEAW:LSE SPDR® MSCI World Health .. 2.93 % 0.00 %

-0.10 (-0.22%)

USD 0.58B
WHEA:SW SPDR MSCI World Health Ca.. 2.93 % 0.00 %

-0.12 (-0.22%)

N/A
MOAT:LSE VanEck Morningstar US Sus.. 2.63 % 0.00 %

-0.41 (-0.22%)

USD 0.50B
MOGB:LSE VanEck Morningstar US Sus.. 2.63 % 0.00 %

-0.27 (-0.22%)

USD 0.50B
ABIE:XETRA AXA IM ACT Biodiversity E.. 2.62 % 0.00 %

-0.03 (-0.22%)

N/A
GMVM:XETRA VanEck Morningstar US Sus.. 2.60 % 0.00 %

-0.30 (-0.22%)

USD 0.53B
MOAT:SW VanEck Morningstar US Sus.. 2.60 % 0.00 %

-0.23 (-0.22%)

N/A
ABIT:XETRA AXA IM ACT Biodiversity E.. 2.42 % 0.00 %

-0.01 (-0.22%)

USD 0.42B
ABIT:F AXA IM ACT Biodiversity E.. 2.42 % 0.00 %

+0.07 (+-0.22%)

N/A
ABIE:F AXA IM ACT Biodiversity E.. 2.42 % 0.00 %

+0.05 (+-0.22%)

N/A
HYLG Global X Funds - Global X.. 1.96 % 0.00 %

-0.20 (-0.22%)

USD 2.85M
XMLH:XETRA L&G Healthcare Breakthrou.. 1.89 % 0.00 %

-0.10 (-0.22%)

USD 0.07B
XMLH:F Legal & General Ucits Etf.. 1.89 % 0.00 %

+0.09 (+-0.22%)

USD 0.07B
DOCT:SW L&G Healthcare Breakthrou.. 1.89 % 0.00 %

-0.10 (-0.22%)

USD 0.07B
DFUV Dimensional US Marketwide.. 1.19 % 0.00 %

-0.54 (-0.22%)

USD 10.54B
JPST JPMorgan Ultra-Short Inco.. 0.74 % 0.00 %

+0.02 (+-0.22%)

USD 23.09B
CWS AdvisorShares Focused Equ.. 0.00 % 0.68 %

-0.43 (-0.22%)

USD 0.15B
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

-0.75 (-0.22%)

USD 3.04B
IBLN 0.00 % 0.64 %

N/A

N/A
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

-0.66 (-0.22%)

USD 3.35B
JHMH 0.00 % 0.46 %

N/A

N/A
LDUR PIMCO Enhanced Low Durati.. 0.00 % 1.02 %

-0.06 (-0.22%)

USD 0.89B
JMIN 0.00 % 0.12 %

N/A

N/A
PSET Principal Quality ETF 0.00 % 0.29 %

-0.50 (-0.22%)

USD 0.05B
LRGE ClearBridge Large Cap Gro.. 0.00 % 0.59 %

+0.16 (+-0.22%)

USD 0.23B
ACT Enact Holdings Inc 0.00 % 0.75 %

-0.78 (-0.22%)

USD 4.95B
KORP American Century Diversif.. 0.00 % 0.45 %

-0.14 (-0.22%)

USD 0.24B
BGU:CA Bristol Gate Concentrated.. 0.00 % 0.85 %

+0.08 (+-0.22%)

CAD 0.11B
FHI:CA CI Health Care Giants Cov.. 0.00 % 0.75 %

N/A

CAD 0.09B
LS:CA Middlefield Healthcare & .. 0.00 % 2.21 %

N/A

CAD 0.16B
HWF:CA 0.00 % 0.00 %

N/A

N/A
HTEC Robo Global® Healthcare .. 0.00 % 0.00 %

-0.42 (-0.22%)

USD 0.06B
CGAA:CA CI Global Asset Allocatio.. 0.00 % 0.00 %

N/A

CAD 0.02B
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
RXD ProShares UltraShort Heal.. 0.00 % 0.77 %

+0.22 (+-0.22%)

USD 0.74M
RXD ProShares UltraShort Heal.. 0.00 % 0.95 %

+0.22 (+-0.22%)

USD 0.74M
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

-2.20 (-0.22%)

USD 0.09B
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

-2.99 (-0.22%)

USD 17.55B
XHC:CA iShares Global Healthcare.. 0.00 % 0.65 %

-0.54 (-0.22%)

CAD 0.60B
XLV Health Care Select Sector.. 0.00 % 0.13 %

-1.60 (-0.22%)

USD 38.77B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

-0.21 (-0.22%)

CAD 0.01B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

-0.16 (-0.22%)

USD 0.40B
DXSI:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

-4.14 (-0.22%)

USD 0.02B
HIG-U:CA 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
OUFH:XETRA 0.00 % 0.00 %

N/A

N/A
IXJ:AU iShares Global Healthcare.. 0.00 % 0.00 %

+1.10 (+-0.22%)

USD 1.31B
DWEQ 0.00 % 0.00 %

N/A

N/A
BGU-U:CA Bristol Gate Concentrated.. 0.00 % 0.00 %

-0.38 (-0.22%)

CAD 0.11B
TDOC:CA TD Global Healthcare Lead.. 0.00 % 0.00 %

-0.16 (-0.22%)

CAD 0.08B
PFUT Putnam Sustainable Future.. 0.00 % 0.00 %

-0.17 (-0.22%)

USD 0.25B
SROI Calamos Antetokounmpo Glo.. 0.00 % 0.00 %

-0.20 (-0.22%)

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.84% 86% B+ 76% C+
Dividend Return 0.07% 14% F 2% F
Total Return 7.91% 86% B+ 73% C
Trailing 12 Months  
Capital Gain 4.76% 75% C 46% F
Dividend Return 0.14% 17% F 1% F
Total Return 4.89% 67% D+ 37% F
Trailing 5 Years  
Capital Gain 105.42% 100% F 88% B+
Dividend Return 1.72% 20% F 5% F
Total Return 107.13% 100% F 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 17.52% 92% A 82% B
Dividend Return 17.75% 83% B 80% B-
Total Return 0.22% 33% F 5% F
Risk Return Profile  
Volatility (Standard Deviation) 23.28% 75% C 49% F
Risk Adjusted Return 76.24% 100% F 93% A
Market Capitalization 56.05B 100% F 99% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 37.46 42% 17%
Price/Book Ratio 4.73 46% 19%
Price / Cash Flow Ratio 26.29 31% 10%
Price/Free Cash Flow Ratio 22.37 31% 11%
Management Effectiveness  
Return on Equity 13.09% 54% 68%
Return on Invested Capital 8.92% 57% 61%
Return on Assets 4.72% 54% 70%
Debt to Equity Ratio 67.01% 38% 50%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.